logo
Plus   Neg
Share
Email

Pembina Pipeline Cuts 2020 Capex Amid COVID-19 Pandemic And Lower Energy Prices

Pembina Pipeline Corp. (PBA,PPL.TO) said it significantly reduced 2020 capital spending amid the COVID-19 pandemic and the recent significant decline in global energy prices. The company has decided to defer some of its expansion projects to reflect the current market reality.

The company will defer projects of Peace Pipeline Phase VII, VIII and IX expansions; Empress Co-generation Facility; Prince Rupert Terminal Expansion.

Pembina will also defer its investment in the integrated propane dehydrogenation plant and polypropylene upgrading facility.

The impact of the measures results in a reduction of C$900 million to C$1.1 billion, or approximately 40 to 50 percent, to the company's previously announced 2020 capital budget of C$2.3 billion. Pembina now expects its revised 2020 capital budget to be C$1.2 billion to C$1.4 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
TJX Companies Inc. is recalling about 92,000 outdoor wooden folding chairs for potential risk of fall and injury hazards, a statement by the U.S. Consumer Product Safety Commission showed. The company said the chairs can break and can pose fall and injury hazards to the user. The company has received 18 reports of the recalled chairs breaking or collapsing, including 15 reports of falls. German automaker Volkswagen AG on Thursday raised its forecast for fiscal 2021 operating margin after reporting a significant growth in first-quarter profit with strong revenues and deliveries. The company also projects significantly higher revenues and deliveries in the full year. Meanwhile, Volkswagen shares were losing around 2 percent in German trading. Biotechnology company Novavax, Inc. (NVAX) announced Thursday that it has finalized an advance purchase agreement (APA) with Gavi, the Vaccine Alliance (Gavi) for supply of its recombinant protein-based COVID-19 vaccine candidate to the COVAX Facility. Under the APA, Novavax is expected to manufacture...
Follow RTT